Shire PLC (LON:SHP) shares rose 0% during trading on Tuesday . The company traded as high as GBX 3,575 ($48.48) and last traded at GBX 3,549.09 ($48.13). Approximately 3,150,000 shares were traded during mid-day trading, an increase of 36% from the average daily volume of 2,310,000 shares. The stock had previously closed at GBX 3,549.09 ($48.13).

SHP has been the topic of a number of research analyst reports. Goldman Sachs Group reissued a “conviction-buy” rating on shares of Shire in a report on Tuesday, October 17th. Shore Capital reissued a “buy” rating on shares of Shire in a report on Monday, November 13th. Liberum Capital lowered their price target on Shire from GBX 4,400 ($59.67) to GBX 4,200 ($56.96) and set a “hold” rating on the stock in a report on Tuesday, October 24th. Morgan Stanley lowered their price target on Shire from GBX 5,800 ($78.65) to GBX 5,700 ($77.30) and set an “overweight” rating on the stock in a report on Thursday, October 12th. Finally, HSBC lowered their price target on Shire from GBX 4,050 ($54.92) to GBX 3,800 ($51.53) and set a “hold” rating on the stock in a report on Tuesday, November 21st. Five equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Shire has a consensus rating of “Buy” and a consensus price target of GBX 5,082.35 ($68.92).

The company has a market cap of $31,840.00 and a PE ratio of 2,737.50.

In related news, insider Dominic Blakemore bought 165 shares of the business’s stock in a transaction dated Tuesday, December 19th. The shares were purchased at an average price of GBX 3,790 ($51.40) per share, with a total value of £6,253.50 ($8,480.47).

COPYRIGHT VIOLATION NOTICE: This article was originally published by Daily Political and is the property of of Daily Political. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.dailypolitical.com/2018/01/18/shire-shp-stock-price-up-0.html.

Shire Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.